zoledronic acid has been researched along with Uterine Cervical Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, Y; Luo, F; Sun, Z; Tu, L; Wang, J; Wang, L; Wang, X; Zhou, Y | 1 |
| Ju, W; Pan, Q; Xu, J | 1 |
| Chou, SC; Lin, YC; Wang, IT | 1 |
| Giraudo, E; Hanahan, D; Inoue, M | 1 |
4 other study(ies) available for zoledronic acid and Uterine Cervical Neoplasms
| Article | Year |
|---|---|
Zoledronic acid inhibits the growth of cancer stem cell derived from cervical cancer cell by attenuating their stemness phenotype and inducing apoptosis and cell cycle arrest through the Erk1/2 and Akt pathways.
Topics: Aldehyde Dehydrogenase 1 Family; Antineoplastic Agents; Apoptosis; Cadherins; Carcinogenesis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Down-Regulation; Female; HeLa Cells; Humans; Integrin alpha6; Isoenzymes; MAP Kinase Signaling System; Nanog Homeobox Protein; Neoplastic Stem Cells; Octamer Transcription Factor-3; Phenotype; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Retinal Dehydrogenase; Signal Transduction; SOXB1 Transcription Factors; Up-Regulation; Uterine Cervical Neoplasms; Zoledronic Acid | 2019 |
Ras inhibition by zoledronic acid effectively sensitizes cervical cancer to chemotherapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Proliferation; Doxorubicin; Drug Synergism; Female; Humans; Male; Mice; Mice, SCID; Paclitaxel; Prenylation; Protein Processing, Post-Translational; ras Proteins; Tumor Cells, Cultured; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays; Zoledronic Acid | 2019 |
Zoledronic acid induces apoptosis and autophagy in cervical cancer cells.
Topics: Apoptosis; Autophagy; Cell Line, Tumor; Cell Survival; Cytokines; Diphosphonates; Female; Humans; Imidazoles; Uterine Cervical Neoplasms; Zoledronic Acid | 2014 |
An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis.
Topics: Angiogenesis Inhibitors; Animals; Cell Movement; Diphosphonates; Enzyme Activation; Female; Humans; Imidazoles; Macrophage Activation; Macrophages; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Mice, Transgenic; Neovascularization, Pathologic; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vascular Endothelial Growth Factors; Zoledronic Acid | 2004 |